Cenata GmbH | Paul-Ehrlich-Str. 23 | D-72076 Tübingen | Tel. 07071 – 565 44 430 | Fax 07071 – 565 44 444

Cenata GmbH | Paul-Ehrlich-Str. 23 | D-72076 Tübingen | Tel. 07071 – 565 44 430 | Fax 07071 – 565 44 444

Home

Fast,
accurate result
Result within an average
of 3 business days
ALLE INFORMATIONENE HIER
Excellent
detection rate
>99% detection rate for trisomy 21
in published studies
ALLE INFORMATIONEN HIER
Low
false-positive rate
Only 0.06% for trisomy 21
ALLE INFORMATIONEN HIER
Highly qualified medical
team for diagnosis
and advice
ALLE INFORMATIONEN HIER
Previous
Next

For physicians

For expectant parents

For physicians

For expectant parents

The Harmony® Test

The Harmony® Test can reliably detect the risk of the chromosomal disorders trisomy 21trisomy 18trisomy 13 as well as X- and Y-chromosomal disorders and DiGeorge syndrome. All aspects of the Harmony® Test are carried out according to european standards of quality and data protection.

Expert opinions on non-invasive prenatal screening test (NIPT)

 

Performing Harmony® Test

Advantages of the Harmony® Test

Excellent detection rate for trisomy 21, 18 and 13

Very low false-positive rate

Fast turnaround time

Excellent clinical validation in studies with more than 148.000 patients

Affordable price

Feasibility under heparin treatment

Latest News

Genomweite Tests aus cfDNA 13. Mai 2020 Seit einiger Zeit werden sog.  NIPT-Verfahren angeboten, die alle 23 Chromosomenpaare untersuchen (sog. genomweites Testen, GW-cfDNA testing). In diesem Zusammenhang möchten wir Sie auf eine bemerkenswerte Publikation aus der Arbeitsgruppe um Prof. Nicolaides hinweisen [1], in der die Ergebnisse der niederländischen TRIDENT-2 Studie und einer Studie aus Belgien bewertet werden.

Read more »

Analysis of the Harmony Test from April 1st, 2022 exclusively in Tübingen, Germany 25. March 2022 We are pleased to inform you that due to the expansion of our laboratory space, all incoming samples will be processed in our Lab in Tübingen from April 1st, 2022. Analysis of the Harmony Test from April 1st, 2022 exclusively in

Read more »

The Harmony® Test

The Harmony® Test can reliably detect the risk of the chromosomal disorders trisomy 21trisomy 18trisomy 13 as well as X- and Y-chromosomal disorders and DiGeorge syndrome. All aspects of the Harmony® Test are carried out according to european standards of quality and data protection.

Expert opinions on non-invasive prenatal screening test (NIPT)

Durchführung Harmony Test

Advantages of the Harmony® Test

Excellent detection rate for trisomy 21, 18 and 13

Very low false-positive rate

Fast turnaround time

Excellent clinical validation in studies with more than 148.000 patients

Affordable price

Feasibility under heparin treatment

Latest News

Genomweite Tests aus cfDNA 13. Mai 2020 Seit einiger Zeit werden sog.  NIPT-Verfahren angeboten, die alle 23 Chromosomenpaare untersuchen (sog. genomweites Testen, GW-cfDNA testing). In diesem Zusammenhang möchten wir Sie auf eine bemerkenswerte Publikation aus der Arbeitsgruppe um Prof. Nicolaides hinweisen [1], in der die Ergebnisse der niederländischen TRIDENT-2 Studie und einer Studie aus Belgien bewertet werden.

Read more »

Analysis of the Harmony Test from April 1st, 2022 exclusively in Tübingen, Germany 25. March 2022 We are pleased to inform you that due to the expansion of our laboratory space, all incoming samples will be processed in our Lab in Tübingen from April 1st, 2022. Analysis of the Harmony Test from April 1st, 2022 exclusively in

Read more »

The Harmony® Test

The Harmony® Test can reliably detect the risk of the chromosomal disorders trisomy 21trisomy 18trisomy 13 as well as X- and Y-chromosomal disorders and DiGeorge syndrome. All aspects of the Harmony® Test are carried out according to european standards of quality and data protection.

Expert opinions on non-invasive prenatal screening test (NIPT)

Durchführung Harmony Test

Advantages of the Harmony® Test

Excellent detection rate for trisomy 21, 18 and 13

Very low false-positive rate

Fast turnaround time

Excellent clinical validation in studies with more than 148.000 patients

Affordable price

Feasibility under heparin treatment

Latest News

Genomweite Tests aus cfDNA 13. Mai 2020 Seit einiger Zeit werden sog.  NIPT-Verfahren angeboten, die alle 23 Chromosomenpaare untersuchen (sog. genomweites Testen, GW-cfDNA testing). In diesem Zusammenhang möchten wir Sie auf eine bemerkenswerte Publikation aus der Arbeitsgruppe um Prof. Nicolaides hinweisen [1], in der die Ergebnisse der niederländischen TRIDENT-2 Studie und einer Studie aus Belgien bewertet werden.

Read more »

Analysis of the Harmony Test from April 1st, 2022 exclusively in Tübingen, Germany 25. March 2022 We are pleased to inform you that due to the expansion of our laboratory space, all incoming samples will be processed in our Lab in Tübingen from April 1st, 2022. Analysis of the Harmony Test from April 1st, 2022 exclusively in

Read more »

Procedure of the Harmony® Test

Genetic counseling

Patient requests the Harmony® Test and gets a genetic counseling by obstetrician or human geneticist

Blood sample

Blood sample is taken and the order form is filled out by physician and patient

Shipping

Blood sample and order form are sent

Test performance

Test is carried out, data is analyzed and the findings are compiled

Receipt of report

Physician reports the findings to the patient including genetic counseling
Scroll to Top